Concepedia

Haruyo Ichikawa

HI

Statistics

Publications

28

Citations

3.7K

H-Index

25

Active since

1990

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Niigata University of Pharmacy and Medical and Life Sciences

Tokyo Women's Medical University

Kyoto University

Kyoto Prefectural University of Medicine

Haruyo Ichikawa is an author at The University of Texas MD Anderson Cancer Center specializing in pharmacology, inflammatory signaling, and nf-κb signaling.

Publications per year

1990–2010

28

Publications

28

Curcumin (Diferuloylmethane) Down-Regulates Expression of Cell Proliferation and Antiapoptotic and Metastatic Gene Products through Suppression of IκBα Kinase and Akt Activation

Sita Aggarwal, Haruyo Ichikawa, Yasunari Takada et al. · Molecular Pharmacology · 2005 · 530 citations

, , +13

Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane)

Santosh K. Sandur, Haruyo Ichikawa, Manoj K. Pandey et al. · Free Radical Biology and Medicine · 2007 · 326 citations · Full text

, , +11

Plumbagin (5-Hydroxy-2-methyl-1,4-naphthoquinone) Suppresses NF-κB Activation and NF-κB-regulated Gene Products Through Modulation of p65 and IκBα Kinase Activation, Leading to Potentiation of Apoptosis Induced by Cytokine and Chemotherapeutic Agents

Santosh K. Sandur, Haruyo Ichikawa, Gautam Sethi et al. · Journal of Biological Chemistry · 2006 · 320 citations · Full text

, , +17

Anticancer potential of silymarin: from bench to bed side.

Rajesh Agarwal, Charu Agarwal, Haruyo Ichikawa et al. · PubMed · 2007 · 293 citations

, , +13

Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-κB (NF-κB) activation and NF-κB–regulated gene expression

Haruyo Ichikawa, Yasunari Takada, Shishir Shishodia et al. · Molecular Cancer Therapeutics · 2006 · 224 citations

, , +14

1–5 of 28